Suppr超能文献

在昆虫和哺乳动物细胞表达系统中对人环氧化酶-2糖基化异质性和蛋白质表达的研究。

Investigation of human cyclooxygenase-2 glycosylation heterogeneity and protein expression in insect and mammalian cell expression systems.

作者信息

Percival M D, Bastien L, Griffin P R, Kargman S, Ouellet M, O'Neill G P

机构信息

Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Quebec, Canada.

出版信息

Protein Expr Purif. 1997 Apr;9(3):388-98. doi: 10.1006/prep.1996.0685.

Abstract

Human cyclooxygenase-2 (hCox-2) is a key enzyme in the biosynthesis of prostaglandins and the target of nonsteroidal anti-inflammatory drugs. Recombinant hCox-2 overexpressed in a vaccinia virus (VV)-COS-7 system comprises two glycoforms. Removal of the N-glycosylation consensus sequence at Asn580 (N580Q and S582A mutants) resulted in the expression of protein comprising a single glycoform, consistent with the partial N-glycosylation at this site in the wild-type (WT) enzyme. The specific cyclooxygenase activities of the purified WT and N580Q mutant were equivalent (40 +/- 3 mumol O2/min/mg) and titrations with diclofenac showed no difference in inhibitor sensitivities of WT and both mutants. Results of the expression of WT and N580Q hCox-2 in a Drosophila S2 cell system were also consistent with the N-glycosylation at this site, but low levels of activity were obtained. High levels of N-glycosylation heterogeneity are observed in hCox-2 expressed using recombinant baculovirus (BV) in Sf9 cells. Expression of a double N-glycosylation site mutant in Sf9 cells, N580Q/N592Q, resulted in a decrease in glycosylation but no clear decrease in heterogeneity, indicating that the high degree of N-glycosylation heterogeneity observed with the BV-Sf9 system is not due to partial glycosylation of both Asn580 and Asn592. N-linked oligosaccharide profiling of purified VV and BV WT and S582A mutant hCox-2 showed the presence of high mannose structures, (Man)n (GlcNAc)2, n = 9, 8, 7, 6. The S582A mutant was the most homogeneous with (Man)9(GlcNAc)2 comprising greater than 50% of oligosaccharides present. Analysis of purified VV WT and S582A mutant hCox-2 by liquid chromatography-electrospray ionization-mass spectrometry showed an envelope of peaks separated by approximately 160 Da, corresponding to differences of a single monosaccharide. The difference between the highest mass peaks of the two envelopes, of approximately 1500 Da, is consistent with the wild-type enzyme containing an additional high mannose oligosaccharide.

摘要

人环氧化酶-2(hCox-2)是前列腺素生物合成中的关键酶,也是非甾体抗炎药的作用靶点。在痘苗病毒(VV)-COS-7系统中过表达的重组hCox-2包含两种糖型。去除Asn580处的N-糖基化共有序列(N580Q和S582A突变体)导致表达的蛋白质只包含一种糖型,这与野生型(WT)酶在此位点的部分N-糖基化情况一致。纯化的WT和N580Q突变体的特异性环氧化酶活性相当(40±3 μmol O2/分钟/毫克),用双氯芬酸进行滴定表明WT和两种突变体对抑制剂的敏感性没有差异。WT和N580Q hCox-2在果蝇S2细胞系统中的表达结果也与此位点的N-糖基化情况一致,但活性水平较低。在杆状病毒(BV)感染的Sf9细胞中表达的hCox-2观察到高度的N-糖基化异质性。在Sf9细胞中表达双N-糖基化位点突变体N580Q/N592Q,导致糖基化减少,但异质性没有明显降低,这表明在BV-Sf9系统中观察到的高度N-糖基化异质性并非由于Asn580和Asn592的部分糖基化。纯化的VV和BV WT以及S582A突变体hCox-2的N-连接寡糖谱分析显示存在高甘露糖结构,(Man)n(GlcNAc)2,n = 9、8、7、6。S582A突变体最为均一,(Man)9(GlcNAc)2占存在的寡糖的50%以上。通过液相色谱-电喷雾电离-质谱对纯化的VV WT和S582A突变体hCox-2进行分析,显示出一系列相隔约160 Da的峰,对应于单个单糖的差异。两个峰系列中最高质量峰之间约1500 Da的差异与野生型酶含有额外的高甘露糖寡糖一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验